GSE236896 GSE237665 DNMT EZH2 inhibition 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE236896_GSE237665_DNMT_EZH2 inhibition_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE236896_GSE237665_DNMT_EZH2 inhibition_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE236896_GSE237665_DNMT_EZH2 inhibition_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE236896_GSE237665_DNMT_EZH2 inhibition_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 4

Gene

cytoskeleton regulator RNA

Gene

ALDH1A3 antisense RNA 1

Gene

MIR924 host gene

Gene

ribosomal protein SA pseudogene 52

Gene

MCM3AP antisense RNA 1

Gene

inositol polyphosphate multikinase pseudogene

Gene

zinc finger family member 767, pseudogene

Gene

long intergenic non-protein coding RNA 2535


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    cytoskeleton regulator RNA


  • Gene

    ALDH1A3 antisense RNA 1



  • Gene

    ribosomal protein SA pseudogene 52


  • Gene

    MCM3AP antisense RNA 1


  • Gene

    inositol polyphosphate multikinase pseudogene


  • Gene

    zinc finger family member 767, pseudogene


  • Gene

    long intergenic non-protein coding RNA 2535

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.